Suneil L. Jain
Lisburn Road
Belfast, NIR, United Kingdom
Belfast, NIR, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 115 publications
PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRT.
Journal: Clinical and translational radiation oncology
Published: February 04, 2026
Characterization of the Three-Flavor Composition of Cosmic Neutrinos with IceCube.
Journal: Physical review letters
Published: October 28, 2025
Raman spectroscopy with machine-learning classification for the prediction of stereotactic radiotherapy induced treatment toxicity in high-risk localised prostate cancer.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: September 29, 2025
Shaping open surgical skills: Eight years of reconstructive urology simulation training in the UK.
Journal: Actas urologicas espanolas
Published: September 03, 2025
Evidence for a Spectral Break or Curvature in the Spectrum of Astrophysical Neutrinos from 5 TeV to 10 PeV.
Journal: Physical review letters
Published: July 29, 2025
An evaluation of rectum contours generated by artificial intelligence automatic contouring software using geometry, dosimetry and predicted toxicity.
Journal: Biomedical physics & engineering express
Published: June 30, 2025
Towards a Biological Evaluation Framework for Oversampling (BEFO) gene expression data.
Journal: Journal of biomedical informatics
Published: February 17, 2025
Search for Extremely-High-Energy Neutrinos and First Constraints on the Ultrahigh-Energy Cosmic-Ray Proton Fraction with IceCube.
Journal: Physical review letters
Published: February 05, 2025
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial.
Journal: The Lancet. Oncology
Published: December 20, 2024
A modified Delphi consensus regarding the clinical utility of triplet therapy in patients with metastatic hormone-sensitive prostate cancer patients in the UK.
Journal: BMJ open
Published: November 28, 2024
Last Updated: 09/26/2026